Maternal and Neonatal Complications of Methamphetamine Use during Pregnancy

Table 3

The comparison studies in patients’ characteristic and pregnancy outcomes.

	Homsup [11]	Good [12]	Wright [2]	Gorman [6]	Thamkhantho [1]	Thaithumyanon [4]	Present
Case	197	276	60	8542	77	178	103
Year	2017	2010	2015	2014	2018	2005	2020
Country	Thailand	US (CA)	US (HI)	US (LA)	Thailand	Thailand	Thailand
GA (weeks)	37.0 ± 2.3		38 ± 2.1		36.9 ± 2.1	38.1 ± 2.3	37.0 ± 2.6
Age			28.4 ± 6.7		24.3 ± 5.8	23.4 ± 5.2	29.2 ± 6.1
ANC			7.5 ± 4.4				2.1 ± 2.8
No ANC				2,178 (25.5)	61 (79.2)	141 (79.2)	48 (46.6)
Preterm	64 (32.5)	133 (50)	8 (13)	1,999 (23.4)	46 (59.7)	55 (30.9)	34 (33.3)
PIH		48 (17)
GHT					4 (5.2)		15 (14.6)
PE	10 (5.1)		4 (6.6)	580 (6.8)		11 (6.2)	5 (4.9)
SPE				213 (2.5)			7 (6.8)
Eclampsia				25 (0.3)	5 (6.49)		0 (0)
Vaginal delivery	174 (88.3)	195 (71)	48 (80.3)		65 (84.4)	146 (82.0)	83 (80.6)
Low APGAR	4 (2)	16 (6)					2 (1.9)
BW (kg)	2.8 ± 0.5		3.1 ± 0.5		2.7 ± 0.4	2.7 ± 0.5	2.8 ± 0.5

GA: gestational age at delivery, ANC: antenatal care, PIH: pregnancy-induced hypertension, GHT: gestational hypertension, PE: preeclampsia with nonsevere feature, SPE: preeclampsia with severe feature, Low APGAR: APGAR score equal to and less than 7 at 5 minutes, BW: average birth weight.